QualityStocks
  The QualityStocks Daily Newsletter for Friday, April 23rd, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

OTC Picks (AGHD)

2.

Penny Stock Chaser (AVOE)

3.

Greenbackers (MRNJ)


The QualityStocks Daily

Alto Group Holdings Inc. (ALTO)

OTC Advisors, Stock Brain, ShamrockStocks.com, and Stock Marketing Inc. reported this month on Alto Group Holdings Inc. (ALTO), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Alto Group Holdings Inc. engages in the acquisition and exploration of mineral properties. The Company is the public vehicle being used to roll-in premium gold (Au), silver (Ag), Copper (Cu) and Nickel (Ni) properties to create an international mining company focused on becoming a medium sized producer. The Company has their corporate headquarters in New York, New York. They trade on NASDAQ's OTCBB.

The Company's mission is to explore, develop and produce gold in favorable jurisdictions where exploration and exploitation is promoted by governments in mining "friendly" territory. They believe that the price of precious metals continuing to move higher against the decline in the dollar combined with looming inflation and unsustainable debt in the U.S. will drive governments' investors to the traditional "safe haven" of gold and precious metals as an investment.

Alto, in the short-term, will explore and develop concessions so that a resource calculation can be made under compliant engineering standards. The Company's intermediate goals are to attain a series of studies from third party engineers proving up the deposits as viable, mineable ventures. Long-term goals for Alto are to take the Company to a production scenario or by creating an inviting target for merger or acquisition by one of the world's top majors.
       
On Tuesday of this week, Alto Group Holdings, Inc. announced the acquisition of the Zuna property. The 750-hectare Zuna exploration prospect is southwest of Los Tres Machos in Mexico. It is on an interesting geologic surface and staked from satellite imagery along the projected fracture seams of the hydrothermal system interpreted regionally from Los Tres Machos.

Testing took place at Zuna during staking in 2006. Thirty-six samples underwent submission for fire assay. The average results of all samples yield 2.13 grams per ton of Au and 126 grams per ton of Ag. Currently, the Company has estimated a 5,000,000-ton deposit and with extensive drilling, the amount may increase substantially. The exploration work will include proper ground controls, mapping, geological, topographical, and geochemical and core drilling. At the same time, Alto Group Holdings Inc.'s exploration shall undertake a program to complete a NI 43-101 to comply with North American geological standards.

Alto Group Holdings Inc. (ALTO) closed Friday's session at $0.0860 up 2.38 percent. Volume was 452,815.

IceWEB Inc. (IWEB)

Stock Marketing Inc., Stock Brain, Stockhunter.us, Bull in Advantage, and Stock Man Says reported this week on IceWEB Inc. (IWEB), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IceWEB, Inc. manufactures and markets purpose built appliances, network, and cloud attached storage solutions and delivers on-line cloud computing application services. Trading on the OTC Bulletin Board, the Company's customer base includes U.S. government agencies, enterprise companies, and small to medium sized businesses (SMB).  IceWEB Inc. Inc. has their headquarters in Sterling, Virginia.

The Company's services are available at a price small businesses can afford. This is through monthly subscription-based services instead of large up-front fees. The hosted software applications operate over the Internet and customers gain immediate access to their web sites, Intranet portals, email systems, and other hosted applications via an Internet connection. IceWEB takes care of all the network infrastructure, data backup/protection, and computer administration tasks.

IceWEB Inc. delivers high performance storage systems for use as Network Attached Storage (NAS) and Storage Area Networks (SAN). In September 2009, the Company introduced the IceWEB Storage System. This is a unified storage architecture, which simplifies the deployment, enhances the features and capabilities, and delivers flexibility to their storage offerings. IceWEB also recently introduced a suite of products called Cloud Storage Appliances (CSA). Cloud Storage Appliances are their patent pending Locally Connected Cloud Storage Devices (LCCSD).

The Company also offers a suite of Cloud Based Software as a Service (SAAS) applications, via their IceWEB Online division. It focuses on enterprise grade Email, Portal, and Email Encryption technologies. IceWEB Online product offerings allow any business to deploy powerful and scalable applications immediately. This is to enhance their business and pay only a reasonable monthly subscription fee based upon services used.

Today, IceWEB, Inc. announced that the IceWEB 5000 Storage System has been selected as the base Storage platform for a Video Sensor project by premier channel partner, VideoBank, Incorporated, for one of their Video Capture implementations at an important Department of Defense customer.  The 5000 has the ability to support both file and block protocols and support for 10G (10GB Ethernet), and FC (Fibre Channel).

IceWEB Inc. (IWEB) closed Friday's trading session at $0.3990 up 4.72 percent. Volume was 1,825,014.

Gulf Island Fabrication Inc. (GIFI)

Gold & Energy Advisor reported previously on Gulf Island Fabrication Inc. (GIFI), and we highlight the Company, here at the Quality Stocks Daily Newsletter.

Gulf Island Fabrication, Inc. operates as a fabricator of offshore drilling and production platforms, hull and deck sections of floating production platforms, and other specialized structures used in the development and production of offshore oil and gas reserves. Headquartered in Houma, Louisiana, the Company has five integrated subsidiaries located in Houma, Louisiana, and Aransas Pass, Texas. They provide their clients with a full range of construction and maintenance services in-shop and out in the field. Founded in 1985, Gulf Island Fabrication Inc. trades on the NASDAQ Global Select Market.

The Company  serves oil and gas exploration and production companies mainly in the Gulf of Mexico, and in north Africa, west Africa, the Middle East, Latin America, the Caribbean, Offshore Canada, and the North Sea. They fabricate jackets and deck sections of fixed production platforms; hull, tendon, and/or deck sections of floating production platforms, such as TLPs, SPARs, FPSOs, and MinDOCs. They also fabricate piles, wellhead protectors, and subsea templates; various production, processing, compressor, and utility modules; offshore living quarters and various other types of steel structures; brown water towboats; and tanks and barges.

Gulf Island Fabrication engages in inshore steel and wood structure construction; and fabrication of pressure vessels and packaged skid units. They also provide services, such as offshore interconnect pipe hook-up, inshore marine construction, manufacture and repair of pressure vessels, heavy lifts, such as ship integration and TLP module integration; loading and offloading jack-up drilling rigs, semi-submersible drilling rigs, TLPs, SPARs, or other similar cargo.

In addition, the Company engages in refurbishing existing platforms; steel warehousing and sales; and onshore and offshore scaffolding and piping insulation services. They also fabricate piles and other rolled goods, templates, bridges for connecting offshore platforms, wellhead protectors, various production, compressor, and utility modules, and other structures used in offshore oil and gas production and development activities.

Gulf Island Fabrication continues to expand facilities and services to increase fabrication capacity. The Company's subsidiaries are Gulf Island, LLC, Gulf Marine Fabricators, Dolphin Services, LLC, Gulf Island Marine Fabricators, LLC, and Dolphin Steel Sales, LLC.

On Wednesday of this week, Gulf Island Fabrication, Inc. reported net income of $4.5 million ($.31 diluted EPS) on revenue of $69.3 million for their first quarter ended March 31, 2010, compared to net income of $6.2 million ($.43 diluted EPS) on revenue of $85.0 million for the first quarter ended March 31, 2009. The Company had a revenue backlog of $144.6 million and a labor backlog of approximately 1.5 million man-hours remaining to work, which consist of work remaining at March 31, 2010 and commitments received through April 21, 2010.

Gulf Island Fabrication Inc. (GIFI) closed Friday's session at $25.49 up 8.10 percent. Volume was 122,985.

iDcentrix, Inc. (IDCX)

Stock Traders Chat reported recently on iDcentrix, Inc. (IDCX), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

iDcentrix, Inc. is a company that engages in the development and production of high-end security identification (ID) cards, and related equipment and consumables. They design these to combat identity fraud and other related criminal activities. Trading on the OTC Bulletin Board, the Company strategy is to sell the ID card production equipment and consumables to government card issuers looking for higher levels of security. Headquartered in El Segundo, California, the Company also issues cards by collaborating with local card manufacturers.

The Company utilizes the LQard Technology to produce cards for high security identity applications. They have patented technology for producing and issuing the first ID card that combines Swiss banknote paper and polycarbonate to produce a credential that has never undergone successful counterfeiting. This is either in tests or in the field. The card also permits easy visual verification, and applies personalized data on the security paper before assembling of the card. Personal data and most security features receive fusing in the card, not on the card. This makes it tamper-resistant.
 
In addition, the card is customizable with a variety of security options from banknote paper features such as watermarks, to current contactless chip technology. The Company's process creates an ID card with a solid outside material that is impregnable. They use no adhesives to compromise security, unlike standard multilayer plastic cards, which can undergo delaminating. The cards transparent border is a security feature that ensures impenetrability of the card. iDcentrix has the exclusive license on this patented technology for North America.
 
The Company has their experts analyze each customer's security and budget requirements. They then recommend the best security options and card topology. They also work with customers to provide a turnkey solution by direct fulfillment, or by providing a desktop card issuance system including consumables. iDcentrix, Inc. is developing strategic relationships with integrators, and technology partners.

iDcentrix, Inc. (IDCX) closed Friday's session at $0.06 up 50.00 percent. Volume was 409,525.

Inolife Technologies, Inc. (INOL)

Today, we choose to highlight Inolife Technologies, Inc. (INOL), here at the QualityStocks Daily Newsletter.

InoLife Technologies, Inc. engages in human and veterinary research and treatment for companion animals. Formerly known as NexxNow, Inc., the Company changed their name to Inolife Technologies, Inc. in January of this year. They have their headquarters in Raleigh, North Carolina and they trade on the OTC Bulletin Board.

The Company's wholly owned subsidiary is InoVet, Ltd. Their mandate is to provide state-of-the-art Veterinary Healthcare products and services. The primary goal of InoVet is to introduce and further develop Bone Marrow Transplantation and other cancer treatment procedures. This is for the benefit of companion animals (dogs and cats) that have lymphoma, other types of cancers, and other diseases that are currently incurable.

Inolife Technologies, Inc. continues to establish working relationships and partnerships with some of the top Veterinary Oncologists and Veterinary Cancer Researchers in the U.S. This is to help the Company bring revolutionary new treatment procedures to the companion animal healthcare market.

The laboratory the Company has collaborated with is a recognized industry leader in the fields of DNA testing and DNA analysis. InoHealth Products, Inc. came about to provide Human Healthcare products and services. The mission of InoHealth focuses solely on the licensing, introduction, marketing, promotion and sales of DNA and genetic testing and analytical products and services on a worldwide basis. The Company's partnership with InoHealth Products, Inc. will be in the marketing and promotion of such products and services.

These products and services will include the IHP DNA Predisposition Test. Their DNA predisposition testing service will reveal genetic predisposition for 25 diseases and conditions. The Company will also offer their IHP Ancestral Origins Test. With their DNA ancestry test, a DNA profile is compared against hundreds of global populations and fourteen anthropological regions whose collective genetic information is known and scientifically validated.

Another example of the products and services the Company will offer is their IHP FDA-Approved Paternity Test. Their FDA Approved Components DNA paternity testing system is a premium 16-marker DNA test. In addition, Inolife Technologies, Inc. will offer their IHP Parental Drug Testing Kit. This test is simple to perform alongside reporting that is clearly presented.

Inolife Technologies, Inc. (INOL) closed Friday's trading session at $0.0064 up 42.22 percent. Volume was 1,529,240.

Genoptix, Inc. (GXDX)

Investment U reported this month on Genoptix, Inc. (GXDX), Zacks.com did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Select Market, Genoptix, Inc. is a specialized laboratory services provider. The Company focuses on delivering personalized and comprehensive diagnostic services. They deliver these services to their physician customers, community-based hematologists, and oncologists. Founded in 1999, Genoptix, Inc. has their headquarters in Carlsbad, California.

The Company's highly trained group of hemepaths employs sophisticated diagnostic technologies. This is to provide a differentiated, specialized, and integrated assessment of a patient's condition. This assists physicians in making vital decisions concerning the treatment of malignancies of the blood and bone marrow and other forms of cancer.

Genoptix, Inc. offers their COMPASS (Comprehensive Assessment) service. COMPASS for Blood and Bone Marrow lets clinicians simplify the diagnostic process.  It helps them make the best treatment decisions for their patients.  With the COMPASS service offering, the Company's hematopathologists determine the appropriate diagnostic tests to be performed. They then integrate patient history and previous and current test results into a comprehensive diagnostic report.

The Company also has their CHART (Comprehensive Hematopathology Assessment and Review over Time) service offering. With the CHART service, the hematologists and oncologists receive a detailed assessment of a patient's disease progression over time. Genoptix will automatically integrate and correlate present results with prior findings, when a follow up or subsequent COMPASS Blood or Bone Marrow evaluation is requested on the same patient.

CHART helps to determine disease progression efficiently and effectively as well as assess residual disease. It also helps to monitor response to treatment and evaluate clonal evolution. Genoptix, Inc. also offers various diagnostic services. This includes professional interpretation by their hematopathologists.

Yesterday, Genoptix, Inc. announced that they expect to report their financial results for the first quarter 2010 after closing of the NASDAQ Global Select Market on Thursday, May 6, 2010. A conference call hosted by President and CEO, Tina S. Nova, Ph.D., and other members of senior management will take place on the same day at 2:00pm PDT (5:00pm EDT) and will be webcast live on the Genoptix website.

Genoptix, Inc. (GXDX) closed Friday's trading session at $38.32 up 0.63 percent. Volume was 197,339.

3DIcon Corporation (TDCP)

OTC Picks, PennyOmega.com and DrStockPick.com reported earlier on 3DIcon Corporation (TDCP), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, 3DIcon Corporation is a developer of volumetric, three-dimension projection and display technologies. The design of these technologies is to produce full color, 360-degree volumetric images. They recently completed a working prototype of their flagship technology, CSpace®, a breakthrough in 3D imaging, along with concluding a key licensing agreement for the CSpace® technology. 3DIcon Corporation has their headquarters in Tulsa, Oklahoma.

Using CSpace®, the displayed 3D data set is viewable in the transparent medium from any perspective angle without the need of wearing goggles. The design of CSpace® provides a volume rendering of the surface and the interior of any organ of the human body. Consequently, adjacent tissues can undergo better monitoring, and more accurate disease diagnosis is possible.

In conjunction with CSpace® hardware, 3DIcon developed a software architecture that can interpret digital imaging and communication in medicine (DICOM) files that can undergo capture by ultrasound devices, magnetic resonance imaging (MRI), or computed tomography (CT) scanners. CSpace® can display the original image in the precise form in which it underwent capture.

CSpace® has no moving parts and requires no special viewing aids to see the projected images. Potential CSpace® benefits also include a scalable projection space, high-resolution display, "sliceability" to zoom in, view cross sections, and high frame, and refresh rates to represent better changing images and movement. CSpace® will also be able to capture and translate data in real time.

3DIcon has also launched their first software product, Pixel Precision®. It targets the R&D market for developers using Texas Instruments' DLP® line of products.

On March 16, 2010, 3DIcon Corporation announced that they expanded their search for potential joint venture partners for their CSpace® flagship program from medical imaging to include various military applications. The Company's licensing partner, Aria International Incorporated, is working to help establish military and related contacts.

3DIcon Corporation (TDCP) closed Friday's trading session at $0.0040 up 14.29 percent. Volume was 612,300.

Advanced Cell Technology Inc. (ACTC)

Ceocast News, PennyOmega.com, Stockpalooza, Stock Stars, OTC Advisors, StockEgg.com, Penny Invest, OTC Picks, HotOTC.com, Cool Penny Stocks, and Penny Stock Finder all reported earlier on Advanced Cell Technology Inc. (ACTC), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. Trading on the OTCBB, the Company specializes in the development of cellular therapies for the treatment of rare and common diseases. They apply stem cell-based technologies and other proprietary methods in the area of regenerative medicine. This is to bring patient-specific therapies from the lab to the bedside. Advanced Cell Technology Inc. has their corporate headquarters in Santa Monica, California, and a laboratory facility in Worcester, Massachusetts.

The Company is currently focusing on three product areas. One is their retinal pigment epithelium (RPE) program. They believe it will yield new therapies for treating disease indications and disorders such as age-related macular degeneration (AMD). Their first therapeutic treatment using their RPE therapy will be a treatment for Stargardt's Disease.

The second is their hemangioblast (HG) cell program. This could yield novel therapies for cardiac diseases such as heart failure. It has successfully completed Phase I human clinical trials. The program has clearance from the FDA to begin Phase II human clinical trials.

The third is the Company's hemangioblast (HG) cell program. They are currently conducting preclinical research programs investigating the possibility of using the cells to treat cardiovascular disease, stroke, and cancer. Their research, published in Nature Methods, demonstrated success in treating vascular indications such as heart attack and limb loss due to vascular damage.

Today, Advanced Cell Technology, Inc. announced that they completed key animal studies in connection with their Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD). The Company filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November.

The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues. The design of the studies was to address the FDA's request for additional data on tumorigenicity and biodistribution. The studies completed in conjunction with Sinclair Research, based in Columbia, Missouri, Charles River Labs, MPI and Althea Labs.

"We believe these animal studies demonstrate an excellent safety profile for our RPE cell therapy," said William M. Caldwell IV, Advanced Cell Technology Inc.'s Chairman & CEO. "We look forward to concluding our discussions with the FDA so that we can commence our study later this year."

Today, Advanced Cell Technology Inc. (ACTC) closed at $0.0990 up 7.96 percent. Volume was 9,881,105.

The QualityStocks Company Corner

Cityside Tickets, Inc. (CIST)

The QualityStocks Daily Newsletter would like to spotlight Cityside Tickets, Inc. (CIST). Today, Cityside Tickets, Inc. closed trading at $0.0330, which was up 19.13 percent. Their volume today was 2,561,978 shares.

Cityside Tickets, Inc. (CIST) offers a diverse range of tickets for sale through their website at www.citysidetickets.com. In addition, visitors to the company’s website can use the site to sell tickets they have available. Cityside Tickets’ focus is on offering tickets to quality theatre acts in a variety of cities.

The company offers concert tickets, theatre tickets, and sports tickets to their customers. Currently, Cityside Tickets is offering concert tickets for acts such as Taylor Swift, Bon Jovi, Lady Gaga, and Elton John & Billy Joel, to name a few. For Theatre tickets, the company is offering tickets for Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, among others.

Cityside Tickets also offers tickets to Major League Baseball, NBA Basketball, NFL Football, and NHL Hockey events. They also offer Monster Jam tickets, National Finals Rodeo tickets, Ultimate Fighting Championship tickets, U.S. Open Tennis Championship tickets, and WWE-World Wrestling Entertainment tickets.

Additionally, Cityside Tickets offers tickets to NASCAR racing events. This includes tickets to the Daytona 500 at Daytona International Speedway as well as the Atlanta Motor Speedway, Darlington Raceway, Indianapolis Motor Speedway, Michigan International Speedway, Pocono Raceway, and Watkins Glen International. This is in addition to a host of other racetrack offerings presented on the company’s web portal. Disclaimer

Cityside Tickets, Inc. Blog

Cityside Tickets, Inc. News:

SectorWatch.biz: Could This be the Hottest Ticket in Town?

CitySide Tickets CEO Highlighted as a Featured Guest on MYOB Radio Show

OTC Signal Daily Stock Watch – CIST

General Environmental Management Inc. (GEVI)

The QualityStocks Daily Newsletter would like to spotlight General Environmental Management Inc. (GEVI) Today, General Environmental Management Inc. closed trading at $0.23, which was up 15.00 percent. Their volume today was 40,000 shares.

General Environmental Management Inc. (GEVI) is in the process of shifting its business focus from hazardous waste field services to the fast growing water treatment and waste-to-energy markets. Since its inception in 2002, the Company has grown at a compounded annual rate of 48% to generate annual revenues of $37M from only $2.3M.

This strategic decision was made after an all inclusive analysis of GEVI's opportunity in the environmental management business. Although the company could work through the current economic downturn and build revenue in its field services business, they believe that shareholders will be rewarded by moving the company into the higher margin, faster growing business segments.

Within the U.S. alone, the water industry is a $120 Billion market that is expected to grow at 6-7% over the next year. On a global basis, the industry size exceeds $400 billion annually and increasing with the demands of a growing world population. The global waste-to-energy market, on the other hand, is a $19.9 billion market with expected CAGR of 6.7% over the next five years.

In order to ensure every advantageous acquisition opportunity is properly evaluated, GEVI has retained the services of General Pacific Partners (GPP). With a very selective and calculated acquisition strategy in place, GEVI is poised for continued success. Disclaimer

General Environmental Management Inc. Blog

General Environmental Management Inc. News:

General Environmental Management Obtains Exclusive Rights for PetroMax Treatment Technology

General Environmental Management Completes Sale of Western Region Field Service Business and Rancho Cordova TSDF to Luntz Acquisition LLC

General Environmental Management Announces Results of Special Meeting of Stockholders

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.0110, which was up 7.84 percent from yesterday's close. Their volume today was 17,000 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB) is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

Kraig Biocraft Laboratories Inc. News:

The New Age of Partnerships

Kraig Biocraft Laboratories, Inc. Greatly Exceeds Its Performance Goals

SectorWatch.biz: Paving the Way for Spider Silk

National Automation Services, Inc. (NASV) 

The QualityStocks Daily Newsletter would like to spotlight National Automation Services, Inc. (NASV). Today National Automation Services, Inc. closed trading at $0.1420, which was up 18.33 percent. Their volume today was 40,000 shares.  

National Automation Services, Inc. (NASV) is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities.  

Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 300 local and regional firms providing automation control services. In general, these companies have an edge on the larger behemoths because they can better respond to the needs of local business and municipalities.  

Unfortunately, for these smaller companies, they compete in a limited market space, have stunted growth prospects and have no way of monetizing their asset value. NAS aims to capitalize on this condition by acquiring and integrating the strongest local and regional players into a new organization that would allow for the synergies and efficiencies of a national company while keeping the competitive advantages of decentralized management and service.  

Of the 300 local and regional automation companies, 42 meet the company’s acquisition criteria; 11 of which have been targeted for acquisition over the next two years. NAS projects year-end 2010 revenues of more than $47 Million and year-end 2011 revenues of over $140 Million predicated on meeting its targeted acquisition schedule. With a solid business plan in place, NAS has a firm foundation to generate strong cash flow and increase shareholder value over the long-term. Disclaimer

National Automotion Services, Inc. Blog

National Automation Services, Inc. News:

National Automation Services, Inc. Secures Equity Financing Commitment for $5 Million

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

CitySide Tickets, Inc. (CIST) Recent Letter of Intent to Acquire StadiumTickets.com

CitySide Tickets, Inc., a nationwide ticket seller poised to quickly become one of the top event ticket providers via acquisition of smaller ticket firms, announced the signing of a Letter of Intent with StadiumTickets.com to acquire 100% ownership.

For CitySide, which owns and operates e-commerce site CitySidetickets.com where users can obtain and also sell tickets to the best in today’s music, sports and theater events, the agreement with StadiumTickets.com, which went live March 1 and began accepting broker orders, is a natural evolution.

Key aspects of StadiumTickets.com include event ticket and real-time entertainment ticket brokering via a secure US/Europe network which is designed to allow brokers to see ticket availability, trade and negotiate rates all through a single, intuitive and feature-rich online portal.

The ticket industry stretches back to the foundations of western civilization, and, while the basic ideas haven’t changed much, the game sure has, with the secondary ticket market seeing massive developments since the 90s. In fact, where it was once dominated by illegal scalpers, it has now transformed into a 21st century business space dominated by technological innovation and e-commerce.

As increasing numbers of people switch to getting their tickets online through secondary brokerages which offer better unique, options and often prices, this sector is experiencing rising demand.
The ticket resale business is ideally suited to e-commerce solutions, according to US research outfit Forrester Research, and with a projected 2012 market value of $4.5 billion in sales and recent industry consolidation like the $265M acquisition of online ticket scalper TicketsNow (2nd largest behind StubHub with $200M in sales in 06) by Ticketmaster, and eBay’s $310M acquisition of StubHub last year, there is clearly potential for massive growth in the sector.

To give an idea of the proportion of overall market activity, StubHub and TicketsNow ranked 4th and 5th among all ticket sites according to internet market research firm Hitwise.
Forrester Research data indicates that advances in computer hardware/software (which drives competition), and the increased tendencies of the consumer base to shop online, are allowing state-of-the-art e-commerce innovators to access the massive growth of this sector.

Given the awesome influx of capital into the sector, and abundant growth potential, CIST is confident that carving out even a small slice of this huge pie will translate effectively into impressive ROI and that even a small percentage of the overall market share will completely validate this aggressive ownership strategy for StadiumTickets.com.

CEO of CIST, Michael DeAmicis, expressed his pleasure over the signing of this Letter of Intent, indicating that this sort of international venture is precisely what the Company had been longing for, and that the real-time connectivity with European brokers would significantly bolster existing “event offerings and ability to procure tickets”, especially in cases where someone wants to get tickets to all the performances in a popular artist’s international tour.

The intuitive CitySidetickets.com lets users search for their favorite artists, venues or all upcoming events within a given ZIP code, and even lets users post tickets to be sold, a boon anyone who has ever bought tickets and missed – or was unable to attend the event – can immediately understand.

TOMI Environmental Solutions, Inc. (TOM) is “One to Watch”

TOMI Environmental Solutions, Inc. is focused on providing environmental services that use UV ozone, activated hydrogen peroxide and UVGI-Filtration to achieve a safe and healthy indoor environment. The company’s equipment will treat and protect homeland security issues that involve infectious disease control. Compared to other existing methods of air remediation and purification, TOMI systems produce byproduct-free ozone and activated hydrogen peroxide mist with a high degree of safety and industry expertise.

According to the American Medical Association (AMA), half of all illnesses may be caused or aggravated by poor indoor air quality. Recognizing this, TOMI’s mission is to ensure that everyone has an opportunity to live, work and play in a healthy indoor environment. To achieve this, the company is diligently working to educate the public about how to achieve excellent indoor air quality and its many health benefits. TOMI offers a unique suite of environmental products and services dedicated to helping consumers and organizations achieve this.

The company’s technology is deployed only by highly trained and certified technicians trained in the proper use of its products. Equipped with advanced technology, their technicians or industrial hygienists assess the air quality of commercial buildings, hospitals, schools, homes, offices, or vehicles and provide the solutions needed to eliminate allergens, asthma triggers, pathogens and contaminates.

In recent news, TOMI announced that it has put into distribution an Ultra-D Directional Mist Adaptor, a 15 foot length hose for the company’s Room Fogger Mark IV unit. Clamping easily to the fogger exhaust port, the adaptor is expected to be a game changer in the remediation and infectious disease control arena.

Dr. Halden Shane, CEO of TOMI, commented, “We are ecstatic at TOMIES to bring this accessory out of development. Using this handheld directional hose, target locations will receive a 6 log bacterial level disinfection with an average of 2-4 micron size droplets, assuring virtually no wetting, will be ideal for keyboards, desktops and other open air disinfection applications. Appropriate Personal Protective Equipment (PPE) is required by the operator. This puts our fogger into a league of its own in the control and disinfection of indoor environments and surfaces.”

He continued, “TOMIES products and applications can help eliminate the 32 billion dollar excessive healthcare costs associated with hospital acquired infections (HAI’s). Irv Kraut, Industrial Hygienist and Director of Environmental Services for TOMIES, sees untapped potential revenue from the use of the Ultra-D Fogger Directional Mist Adaptor on HVAC evaporator coils, drip pans and hard and soft surfaces that are contaminated in tight and inaccessible areas. “Our fogger will be revolutionary in the air and surface remediation industry.”

NeoStem Inc. (NBS) Inks Collaborative Agreement with ImmuneRegen (IRBS) to Advance Adult Stem Cell Technology

NeoStem Inc., an international biopharmaceutical company with operations in the U.S. and China, has entered into a collaborative research agreement with ImmuneRegen BioSciences Inc., a wholly owned subsidiary of IR BioSciences Holdings Inc. (IRBS).

The companies will work together to develop an advanced, adult human stem cell product. Per the agreement, NeoStem will observe and analyze the effects of ImmuneRegen’s lead drug candidate Homspera(R) in combination with NeoStem’s VSEL(TM) technology.

NeoStem provides adult stem cell banking services and is pursuing further research and development of adult stem cell therapies for regenerative purposes in the U.S. and China. The agreement will center on Homspera’s ability to enhance the development of adult stem cells.
“Collaborating with NeoStem will allow ImmuneRegen to accelerate the development of Homspera(R) for adult stem cell applications while, in parallel, supporting other clinical applications of Homspera,” Hal Siegel, Ph.D., ImmuneRegen’s vice president and CEO stated in the press release. “Based on our previous findings that Homspera enhances the development of adult hematopoietic stem cells, we are eager to move forward into broader applications using VSEL(TM) technology with NeoStem. Additionally, marketing opportunities in China are especially interesting for these novel stem cell applications.”

NeoStem’s stem cell harvesting marks an integral step toward overcoming two main challenges of stem cell therapy: the controversy regarding the ethics behind embryonic stem cell use and the immunological problems associated with using donor stem cells.

“We look forward to working with the ImmuneRegen team to evaluate the practical application of our exclusive VSEL(TM) technology and advance our effort in the development of adult stem cell-based therapies,” said Robin Smith, M.D., NeoStem’s chairman and CEO. “Very small embryonic-like stem cells have the potential to improve the diagnosis and treatment of many diseases, including neural, cardiac, orthopedic disorders, and the company is committed to advancing the broad potential applications of the VSEL(TM) technology for diagnostic and therapeutic uses internally and through additional collaborative partnerships in the U.S. and China.”

According to the agreement, NeoStem has the right to execute an option agreement to negotiate an exclusive license to resulting technology. ImmuneRegen and NeoStem’s collaborative efforts will focus on expanding applications of VSEL.

Island Breeze International, Inc. (IBII) Enters Joint Venture and Investment Agreement

Island Breeze International Inc. is focused on developing and operating entertainment cruise projects. The company is currently evaluating port locations in East Asia for the establishment of its initial operations. Island Breeze announced today it has entered into a joint venture and investment agreement with a private investment group.

Under the terms of the joint venture and investment agreement, Island Breeze International will form a new subsidiary for the purpose of acquiring an existing overnight cruise vessel to operate in East Asia. In addition, the private investment group has committed to make a $600,000 equity investment into the company. Furthermore, the group will lend up to an additional $14.4 million to a subsidiary which the company will organize to facilitate the vessel acquisition and subsequent operations.

The president and CEO of Island Breeze, Bradley T. Prader, commented, “This joint venture will provide the company with the additional financial resources in order to implement its strategy. This agreement is a major milestone towards our goal of establishing the company’s initial operations in East Asia.”

Island Breeze also announced that it has entered into a definite agreement to sell the Casino Royale, one of two vessels it currently owns. Concerning the sale of this vessel, Mr. Prader said, “Not only will the sale of the Casino Royale greatly reduce our overall overhead costs, but it is also a major step in implementing our plan of investing in overnight cruise assets that are better suited to operate in the East Asian market as a result of longer anticipated cruise durations.”

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336